Researchers from Rice University and Baylor College of Medicine have demonstrated a groundbreaking treatment that eradicates ...

Innovent Biologics has made the case that its checkpoint inhibitor-cytokine fusion protein has a future in colorectal cancer.

Phase 1b diffuse large B-cell lymphoma (DLBCL) trial . Cohort A: 6 patients were treated with azer-cel and lymphodepleti ...

GlobalData’s report assesses the drugs in the Interleukin 2 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

Cytokines enable communication between immune cells, encouraging their proliferation, differentiation, and functional activation. For example, interleukin-2 (IL-2) improves T cell proliferation and ...

Vivtex to apply its GI-ORIS™ technology to optimize oral bioavailability of EQ302, Equillium’s novel IL-15/IL-21 bi-specific peptide ...

BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class ...

Rice University and Baylor College of Medicine have received $2.8 million in funding from the National Heart, Lung, and Blood ...

The phase IIIA trials randomized 792 patients ages 12 and older with severe asthma in a 2:1 ratio to depemokimab (100 mg ...

Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of ...